MondegarAI
← Tracker

Institutional

Boxer Capital Management, LLC

CIK 0002018299
$761.7M
Reported AUM
54
Positions
Q1 2026
Period
2026-05-15
Filed

The Brief · Boxer Capital Management, LLC · Q1 2026

AI · grounded in 13F

Boxer Capital Management, LLC closed its position in CDTX for a reduction of $11.7M. The fund established new positions in PCVX and [[stock:CRVS], valued at $18.9M and $16.1M respectively. Additionally, the fund increased its holdings in VIR by 198.56% and SRZN by 84.14%.

Portfolio · Q1 2026

TNGX$227.5MKOD$51.9MRVMD$48.6MKYMRCELCSRZNABVXTERNSPCVXCAPRPTGXVIROther$244.7MBL

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1TNGXTANGO THERAPEUTICS INC$27.6936.94%374.65%101.72%$227.5M29.87%HELD
2KODKODIAK SCIENCES INC$31.05-9.10%635.78%-62.97%$51.9M6.81%+225,000+19.8%
3RVMDREVOLUTION MEDICINES INC$149.23-4.15%263.18%421.05%$48.6M6.38%+100,000+25.0%
4KYMRKYMERA THERAPEUTICS INC$74.670.73%55.67%23.18%$27.4M3.60%HELD
5CELCCELCUITY INC$88.24-0.05%576.48%348.12%$25.7M3.37%HELD
6SRZNSURROZEN INC$21.52-11.73%153.18%-85.61%$22.3M2.93%+350,168+84.1%
7ABVXABIVAX SA$101.53-3.24%1139.68%900.30%$22.3M2.92%+75,000+60.0%
8430TERNS PHARMACEUTICALS INC$19.8M2.60%HELD
9PCVXVAXCYTE INC$46.38-2.06%28.03%118.45%$18.9M2.48%+325,000NEW
10CAPRCAPRICOR THERAPEUTICS INC$26.62-0.34%87.70%511.21%$17.9M2.35%+265,000+81.5%
11PTGXPROTAGONIST THERAPEUTICS INC$97.38-5.26%79.07%97.01%$17.9M2.35%HELD
12VIRVIR BIOTECHNOLOGY INC$8.59-0.69%58.72%-75.74%$16.7M2.20%+1,241,000+198.6%
13CRVSCORVUS PHARMACEUTICALS INC$11.230.99%184.40%432.06%$16.1M2.11%+1,100,000NEW
14PRAXPRAXIS PRECISION MEDICINES I$254.00-4.06%470.02%8.55%$15.0M1.97%HELD
15PTCTPTC THERAPEUTICS INC$70.970.47%36.14%85.16%$13.6M1.79%HELD
16PGENPRECIGEN INC$3.58-7.25%138.67%-34.79%$13.5M1.78%+2,125,000+154.5%
17DFTXDEFINIUM THERAPEUTICS INC$23.55-4.23%202.31%-48.69%$11.3M1.49%+598,500NEW
18AMLXAMYLYX PHARMACEUTICALS INC$13.32-6.92%149.91%-59.51%$11.1M1.46%HELD
19QUREUNIQURE NV$26.45-5.50%53.16%-8.82%$10.8M1.42%+372,000+128.3%
20IRDOPUS GENETICS INC$4.03-13.15%287.50%-4.05%$10.2M1.34%+2,250,000NEW
21CORTCORCEPT THERAPEUTICS INC$73.991.89%4.34%249.64%$10.1M1.32%+250,000NEW
22URGNUROGEN PHARMA LTD$26.85-2.72%264.31%73.23%$9.0M1.18%HELD
23REPLREPLIMUNE GROUP INC$8.89-6.13%-8.77%-71.07%$9.0M1.18%+425,000+56.7%
24COGTCOGENT BIOSCIENCES INC$31.02-5.40%356.18%417.00%$8.7M1.14%HELD
25PALIPALISADE BIO INC$1.74-9.84%148.57%-99.92%$8.4M1.10%HELD
26CRESCENT BIOPHARMA INC.$8.3M1.09%+453,686NEW
27SLNOSOLENO THERAPEUTICS INC$53.010.00%-29.80%288.35%$6.7M0.88%+200,000NEW
28ALLOALLOGENE THERAPEUTICS INC$1.82-3.19%32.39%-91.44%$6.6M0.87%+2,725,000NEW
29CYTKCYTOKINETICS INC$70.51-1.35%121.30%140.84%$6.6M0.87%HELD
30CTNMCONTINEUM THERAPEUTICS INC$11.49-6.89%141.89%-25.00%$6.5M0.85%HELD
31APGEAPOGEE THERAPEUTICS INC$86.92-4.38%$5.9M0.77%HELD
32RLMDRELMADA THERAPEUTICS INC$5.95-5.71%$5.9M0.77%+842,106NEW
33ZURAZURA BIO LTD$3.40-7.36%$5.4M0.70%+850,000+1700.0%
34MLTXMOONLAKE IMMUNOTHERAPEUTICS$18.070.92%$5.1M0.67%HELD
35AVTXAVALO THERAPEUTICS INC$13.432.52%$4.5M0.59%+25,000+9.1%
36INOINOVIO PHARMACEUTICALS INC$1.102.34%$4.1M0.54%50,000−2.1%
37GPCRSTRUCTURE THERAPEUTICS INC$37.58-3.79%$3.6M0.47%HELD
38SRPTSAREPTA THERAPEUTICS INC$15.75-5.46%$3.3M0.43%HELD
39HELPCYBIN INC$4.15-6.32%$3.1M0.40%75,000−10.5%
40OCULOCULAR THERAPEUTIX INC$8.25-6.25%$3.0M0.39%+350,000NEW
41ANTXAN2 THERAPEUTICS INC$3.953.47%$2.6M0.34%+749,035NEW
42CLNNCLENE INC$5.44-0.18%$2.4M0.31%+277,778+139.1%
43ORICORIC PHARMACEUTICALS INC$7.50-6.48%$2.2M0.29%+176,500NEW
44SLDBSOLID BIOSCIENCES INC$6.55-2.24%$2.2M0.28%HELD
45IVVDINVIVYD INC$1.03-7.21%$1.9M0.26%HELD
46LBRXLB PHARMACEUTICALS INC$28.53-1.28%$1.7M0.23%HELD
47KPTIKARYOPHARM THERAPEUTICS INC$9.080.11%$1.7M0.22%+50,000+19.8%
48NRIXNURIX THERAPEUTICS INC$14.64-4.19%$1.6M0.20%HELD
49UPBUPSTREAM BIO INC$7.05-5.11%$1.4M0.18%HELD
50MISTMILESTONE PHARMACEUTICALS IN$1.23-4.65%$793K0.10%HELD
51PEPGPEPGEN INC$1.41-4.73%$483K0.06%101,000−27.0%
52KALVKALVISTA PHARMACEUTICALS INC$26.950.00%$411K0.05%HELD
53RGNXREGENXBIO INC$6.03-0.82%$126K0.02%+15,000NEW
54SRZNWSURROZEN INC$0.020.00%$1K0.00%HELD
55CDTXCIDARA THERAPEUTICS INC53,000EXITED
56BRD1EURMIND MEDICINE MINDMED INC598,500EXITED
57CBIOCRESCENT BIOPHARMA INC.$18.00-2.44%453,686EXITED
58NUVB/WSNUVATION BIO INC266,666EXITED

Source: SEC EDGAR · accession 0001213900-26-057335. 13F discloses long positions only — shorts, foreign equities, and options are excluded.